Primary effects of intravitreal bevacizumab inpatients with diabetic macular edema
DOI:
https://doi.org/10.12669/pjms.294.3735Keywords:
Best Corrected Visual Acuity (BCVA), Central Macular Thickness (CMT), Diabetic Macular Edema (DME), Intra Vitreal Bevacizumab (IVB).Abstract
Objective: To evaluate the efficacy of primary intra vitreal bevacizumab (IVB) injection on macular edema in diabetic patients with improvement in best corrected visual acuity (BCVA) and central macular thickness (CMT) on optical coherence tomography (OCT).
Methods: This prospective interventional case series
Downloads
Published
2013-07-03
How to Cite
-Ul-haq, T. I., Rahman, A., Mahar, P., & Memon, M. S. (2013). Primary effects of intravitreal bevacizumab inpatients with diabetic macular edema. Pakistan Journal of Medical Sciences, 29(4). https://doi.org/10.12669/pjms.294.3735
Issue
Section
Original Articles





